Additionally, serum levels of FGF21 were associated with metabolic parameters, including BMI, serum glucose levels, and serum TG levels, suggesting that FGF21 may mediate the association between obesity and tumor progression in PTC. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.